Sweet Bee Venom Pharmacopuncture as a Sole Treatment for Verruca Vulgaris: A Case Report

Article information

J Korean Med. 2025;46(3):182-190
Publication date (electronic) : 2025 September 1
doi : https://doi.org/10.13048/jkm.25043
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University
Correspondence to: Kwang-sik Yoon, College of Korean Medicine, Daejeon University, 32, Beobwon-ro 11-gil, Songpa-gu, Seoul, Republic of Korea, Tel: +82-2-2222-8103, E-mail: love6605@naver.com
Received 2025 July 14; Revised 2025 July 28; Accepted 2025 August 12.

Abstract

Objectives

This case report aims to present the clinical course of a patient with verruca vulgaris who was treated solely with sweet bee venom pharmacopuncture, highlighting its potential as an alternative therapeutic option.

Methods

Sweet bee venom pharmacopuncture treatment was performed regularly once a week. The injection needle was angled toward the center of the lesion during administration. Prior to treatment initiation, a skin test was conducted to assess hypersensitivity to bee venom. No other complementary Korean medicine treatments were administered alongside the sweet bee venom pharmacopuncture.

Results

At the end of treatment, the lesion was almost completely resolved, leaving only mild pigmentation and scarring. No signs of recurrence were noted throughout the one-year follow up period, and the skin condition remained stable.

Conclusions

The immunomodulatory and antiviral effects of sweet bee venom pharmacopuncture appeared to contribute positively to lesion improvement and tissue regeneration. Further clinical studies, such as randomized controlled trials, are required to better assess the effectiveness of sweet bee venom pharmacopuncture when used alone or alongside other therapeutic approaches for verruca vulgaris.

Fig. 1

Clinical image of verruca vulgaris on September 26, 2023, prior to treatment.

Fig. 2

Clinical image of verruca vulgaris during treatment (stage 1) on October 2, 2023.

Fig. 3

Clinical image of verruca vulgaris during treatment (stage 2) on December 18, 2023

Fig. 4

Clinical image of verruca vulgaris during treatment (stage 3) on January 15, 2024

Fig. 5

Clinical image of verruca vulgaris during treatment (stage 4) on February 28, 2024

Fig. 6

Clinical image of verruca vulgaris at one-year follow up on February 17, 2025.

References

1. Moon Y. K., Jeong W. Y., Kim Y. B., Nam H. J., Kim N. K.. 2015;Three cases of verruca vulgaris treated mainly with Gwakhyangjeonggisangamibang and moxibustion. J Korean Med Ophthalmol Otolaryngol Dermatol 28(2):93–101. http://dx.doi.org/10.6114/jkood.2015.28.2.093.
2. Lee J. H., Shim G. S.. 2015;Five cases of viral warts treated by Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol 28(2):121–129. http://dx.doi.org/10.6114/jkood.2015.28.2.121.
3. Lee K. Y.. 2019;Analysis of case studies on warts treated with Oriental medicine. J Korean Med Ophthalmol Otolaryngol Dermatol 32(4):101–115. http://dx.doi.org/10.6114/jkood.2019.32.4.101.
4. Lee J. C., Choi J. H., Park S. Y., Choi J. H., Kim J. H.. 2012;A case of treatment of verruca plana. J Korean Med Ophthalmol Otolaryngol Dermatol 25(2):76–82.
5. Text of traditional Korean dermatology & surgery. 2007. Korean traditional dermatology association textbook compliation committee Busan: Sunwoo. p. 432–434.
6. Kim J. H., Seo H. S., Lee M. E., Jeong M. R., Kwon K.. 2021;A case report of verruca vulgaris patient, treated only with Korean medicine. J Korean Med Ophthalmol Otolaryngol Dermatol 34(4):154–163. https://doi.org/10.6114/jkood.2021.34.4.154.
7. Textbook of Dermatology 6th editionth ed. 2014. Korean Dermatological Association. Seoul: Daehaneuihak. p. 472–476.
8. Lee S. Y., Kim S. H., Son H. O., Chun S. W., Song J. S., Cho H. K.. 2013;A clinical study on viral warts in five-year-period(2007~2011). Korean J Dermatol 51(8):593–599.
9. Yun Y. H., Choi I. W.. A case report of verruca plana. 2008;J Korean Oriental Med 29(3):161–168.
10. Yun J. M., Shin S. H., Yoon H. J., Ko W. S.. 2010;Combination therapy with Gwakhyangjeong-gisangamibang and Sojangjeonggyeok for the treatment of verruca plana. J Korean Med Ophthalmol Otolaryngol Dermatol 23(1):169–181.
11. Jeong D. H., Sim S. H., Choi J. H.. 2003;A case of treatment of flat wart. J Korean Med Ophthalmol Otolaryngol Dermatol 16(1):226–235.
12. Yoon J. W., Yoon S. W., Yoon H. J., Ko W. S.. 2002;A case report of plane wart. Korean J Oriental Physiology & Pathology 16(5):1070–1074.
13. Yun J. M., Shin S. H., Yoon H. J., Ko W. S.. 2009;A statistical study of patients visited wart clinic. J Korean Med Ophthalmol Otolaryngol Dermatol 22(2):192–200.
14. Lim H. Y., Yoon H. W., Ko W. S.. 2020;A case of verruca vulgaris in a pediatric patient treated with aroma therapy-based Korean medicine by tea tree oil(melaleuca alternifolia). J Korean Med Ophthalmol Otolaryngol Dermatol 33(3):162–170. https://doi.org/10.6114/jkood.2020.33.3.162.
15. Jung J. W., Kim S. H.. Case report on systemic lupus erythematosus improved by bee venom pharmacopuncture and herb medicine. 2020;J Korean herbal medicine information 8(2):225–231. http://dx.doi.org/10.22674/KHMI-8-2-8.
16. Kim H. J., Ji Y. S., Lee S. M., Jeon J., Kim Y. I.. 2013;A systemic review of clinical study of bee venom acupuncture. Journal of acupuncture research 30(4):151–159. http://dx.doi.org/10.13045/acupunct.2013031.
17. Lee J. H., Lee J. H., Gwak D. W.. 2024;LP-Nd:YAG laser treatment of warts with optimal parameters: a case report. J Korean Med Ophthalmol Otolaryngol Dermatol 37(4):162–170. https://doi.org/10.6114/jkood.2024.37.4.104.
18. Lim J. Y., Kim H. S., Kim J. I., Min J. H., Choi Y. J., Nam J. H., et al. 2017;A case of combination treatment with oral acitretin and tropical 5% imiquimod cream in an immunosuppressive patient with widespread verruca plana. Korean J Dermatol 55(9):597–601.
19. Kim J. E., Kim I. W., Son S. W.. 2006;A retrospective analysis of efficacy and recurrence rate for viral warts treated by cryotherapy. Korean J Dermatol 44(8):931–936.
20. Kwon I. H., Lee J. H., Kim J. A., Cho K. H.. 2003;Study of the ideal method in cryotherapy of wart. Korean J Dermatol 41(9):1193–1197.
21. Kim T. Y., Kim D. H., Yoon M. S.. 2009;The efficacy of topical photodynamic therapy with a Light-emitting diode(LED) device for recalcitrant hand and foot warts. Korean J Dermatol 47(10):1141–1148.
22. Kim T. W., Jwa S. W., Song M., Kim H. S., Ko H. C., Kim B. S.. 2012;Five cases of onychatrophy following bleomycin intralesional injections for periungual warts. Korean J Dermatol 50(3):262–265.
23. Lee Y. B., Park H. J., Lee J. Y., Cho B. K.. 2007;The safety and efficacy of cimetidine therapy for periungual warts. Korean J Dermatol 45:1258–1264.

Article information Continued

Fig. 1

Clinical image of verruca vulgaris on September 26, 2023, prior to treatment.

Fig. 2

Clinical image of verruca vulgaris during treatment (stage 1) on October 2, 2023.

Fig. 3

Clinical image of verruca vulgaris during treatment (stage 2) on December 18, 2023

Fig. 4

Clinical image of verruca vulgaris during treatment (stage 3) on January 15, 2024

Fig. 5

Clinical image of verruca vulgaris during treatment (stage 4) on February 28, 2024

Fig. 6

Clinical image of verruca vulgaris at one-year follow up on February 17, 2025.